Eli Reichman Email

Production and R&D employee . Entera Bio

Current Roles

Employees:
23
Revenue:
$3.6M
About
Entera Bio is a product-focused biotechnology company specializing in the oral delivery of large molecules and biologics. Entera Bio is currently conducting clinical trials on its proprietary technology which allows oral delivery of large molecules and biologics while enhancing their absorption in the GI tract. Entera Bio's technology addresses the two major problems of oral drug delivery of large molecule APIs (active pharmaceutical ingredients). Most large molecules cannot be administered orally as they are not readily absorbed by the gastrointestinal tract and are rapidly degraded by a myriad of enzymes and acids in the gastrointestinal tract. Entera's Proprietary Technologies Act Synergistically to Transport and Protect Large Molecules.
Entera Bio Address

null, null
Entera Bio Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.